Detailed information for compound 1274080

Basic information

Technical information
  • TDR Targets ID: 1274080
  • Name: 1-[2-(diethylsulfamoyl)-4-methylphenyl]-3-pyr idin-3-ylthiourea
  • MW: 378.512 | Formula: C17H22N4O2S2
  • H donors: 1 H acceptors: 3 LogP: 2.7 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN(S(=O)(=O)c1cc(C)ccc1N=C(Nc1cccnc1)S)CC
  • InChi: 1S/C17H22N4O2S2/c1-4-21(5-2)25(22,23)16-11-13(3)8-9-15(16)20-17(24)19-14-7-6-10-18-12-14/h6-12H,4-5H2,1-3H3,(H2,19,20,24)
  • InChiKey: MRIRJFPMNNSBLD-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[2-(diethylsulfamoyl)-4-methyl-phenyl]-3-(3-pyridyl)thiourea
  • 1-[2-(diethylsulfamoyl)-4-methylphenyl]-3-(3-pyridyl)thiourea
  • 1-[2-(diethylsulfamoyl)-4-methyl-phenyl]-3-pyridin-3-yl-thiourea
  • SMR000372501
  • T0520-0095
  • MLS000774734
  • ZINC03281805

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens survival of motor neuron 2, centromeric Starlite/ChEMBL No references
Homo sapiens ATPase family, AAA domain containing 5 Starlite/ChEMBL No references
Homo sapiens multiple endocrine neoplasia I No references
Homo sapiens lysine (K)-specific methyltransferase 2A Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi hypothetical protein Get druggable targets OG5_132873 All targets in OG5_132873
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Schistosoma mansoni hypothetical protein Get druggable targets OG5_133913 All targets in OG5_133913
Toxoplasma gondii histone lysine methyltransferase SET1 Get druggable targets OG5_130642 All targets in OG5_130642
Schistosoma japonicum Menin, putative Get druggable targets OG5_133913 All targets in OG5_133913
Schistosoma mansoni mixed-lineage leukemia protein mll Get druggable targets OG5_130642 All targets in OG5_130642
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Echinococcus multilocularis dnaJ subfamily B Get druggable targets OG5_133913 All targets in OG5_133913
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132873 All targets in OG5_132873
Neospora caninum Multidomain chromatinic protein with the following architecture: 3x PHD-bromo-3xPHD-SET domain and associated cysteine cluster a Get druggable targets OG5_130642 All targets in OG5_130642
Echinococcus granulosus survival motor neuron protein 1 Get druggable targets OG5_132873 All targets in OG5_132873
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Schistosoma japonicum ko:K09188 myeloid/lymphoid or mixed-lineage leukemia protein 3, putative Get druggable targets OG5_130642 All targets in OG5_130642
Echinococcus multilocularis survival motor neuron protein 1 Get druggable targets OG5_132873 All targets in OG5_132873
Echinococcus multilocularis atpase aaa+ type core atpase aaa type core Get druggable targets OG5_139225 All targets in OG5_139225
Echinococcus granulosus dnaJ subfamily B Get druggable targets OG5_133913 All targets in OG5_133913

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.1434 0.2482
Onchocerca volvulus 0.0035 0.0311 0.5624
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0036 0.5
Plasmodium vivax ataxin-2 like protein, putative 0.003 0.0267 0.5
Schistosoma mansoni hypothetical protein 0.0014 0.0095 0.0164
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Schistosoma mansoni cpg binding protein 0.0037 0.0331 0.0573
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0036 0.5
Schistosoma mansoni hypothetical protein 0.0058 0.0552 0.0956
Echinococcus multilocularis cpg binding protein 0.0037 0.0331 0.0331
Brugia malayi F/Y-rich N-terminus family protein 0.0011 0.0064 0.011
Brugia malayi hypothetical protein 0.003 0.0267 0.0462
Loa Loa (eye worm) histone methyltransferase 0.0011 0.0065 0.0113
Brugia malayi MH1 domain containing protein 0.0005 0.0011 0.0018
Echinococcus multilocularis dnaJ subfamily B 0.0494 0.5022 0.5022
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0005 0.0006 0.001
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0011 0.0065 0.0065
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Echinococcus granulosus Smad4 0.001 0.0056 0.0096
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0036 0.5
Brugia malayi MH2 domain containing protein 0.001 0.0056 0.0096
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0014 0.0095 0.0095
Loa Loa (eye worm) camk/mapkapk/mapkapk protein kinase 0.0568 0.5778 1
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0074 0.071 0.1228
Echinococcus multilocularis mothers against decapentaplegic 5 0.001 0.0056 0.0056
Brugia malayi Smad1 0.001 0.0056 0.0096
Leishmania major hypothetical protein, conserved 0.003 0.0267 0.5
Schistosoma mansoni smad1 5 8 and 0.001 0.0056 0.0096
Loa Loa (eye worm) nuclear factor I 0.0005 0.0011 0.0018
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0009 0.0043 0.0075
Schistosoma mansoni smad1 5 8 and 0.001 0.0056 0.0096
Echinococcus granulosus MAP kinase activated protein kinase 2 0.0568 0.5778 1
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0009 0.0043 0.0075
Echinococcus multilocularis Smad4 0.001 0.0056 0.0056
Brugia malayi MH1 domain containing protein 0.0005 0.0011 0.0018
Echinococcus multilocularis smad 0.001 0.0056 0.0056
Brugia malayi MH1 domain containing protein 0.001 0.0056 0.0096
Loa Loa (eye worm) MH1 domain-containing protein 0.001 0.0056 0.0096
Echinococcus multilocularis survival motor neuron protein 1 0.0286 0.2884 0.2884
Schistosoma mansoni smad1 5 8 and 0.001 0.0056 0.0096
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0036 0.5
Brugia malayi MH2 domain containing protein 0.001 0.0056 0.0096
Echinococcus multilocularis MAP kinase activated protein kinase 2 0.0568 0.5778 0.5778
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Schistosoma mansoni cpg binding protein 0.0037 0.0331 0.0573
Schistosoma mansoni TGF-beta signal transducer Smad2 0.001 0.0056 0.0096
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.1434 0.2482
Echinococcus multilocularis TGF beta signal transducer SmadC 0.001 0.0056 0.0056
Loa Loa (eye worm) CXXC zinc finger family protein 0.0035 0.0311 0.0538
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0036 0.5
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0009 0.0043 0.0043
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.0267 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0267 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0267 0.5
Loa Loa (eye worm) hypothetical protein 0.003 0.0267 0.0462
Brugia malayi MH1 domain containing protein 0.001 0.0056 0.0096
Loa Loa (eye worm) Smad1 0.001 0.0056 0.0096
Brugia malayi hypothetical protein 0.002 0.0157 0.0271
Brugia malayi Iron-sulfur cluster assembly accessory protein 0.0058 0.0552 0.0956
Loa Loa (eye worm) hypothetical protein 0.0286 0.2884 0.4992
Schistosoma mansoni Smad4 0.001 0.0056 0.0096
Brugia malayi map kinase activated protein kinase protein 2 0.0568 0.5778 1
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0008 0.0036 0.5
Schistosoma mansoni hypothetical protein 0.0494 0.5022 0.8691
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Echinococcus granulosus smad 0.001 0.0056 0.0096
Echinococcus granulosus survival motor neuron protein 1 0.0286 0.2884 0.4992
Brugia malayi MH2 domain containing protein 0.0144 0.1434 0.2482
Loa Loa (eye worm) MH2 domain-containing protein 0.001 0.0056 0.0096
Echinococcus granulosus cpg binding protein 0.0037 0.0331 0.0573
Toxoplasma gondii histone lysine methyltransferase SET1 0.0066 0.0629 1
Echinococcus multilocularis mixed lineage leukemia protein mll 0.0009 0.0043 0.0043
Brugia malayi hypothetical protein 0.0286 0.2884 0.4992
Echinococcus granulosus dnaJ subfamily B 0.0494 0.5022 0.8691
Schistosoma mansoni smad 0.001 0.0056 0.0096
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Echinococcus granulosus mothers against decapentaplegic 5 0.001 0.0056 0.0096
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0267 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.0267 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0036 0.5
Trichomonas vaginalis helicase, putative 0.0008 0.0036 0.5
Onchocerca volvulus 0.0058 0.0552 1
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0011 0.0065 0.0113
Loa Loa (eye worm) hypothetical protein 0.0005 0.0011 0.0018
Schistosoma mansoni survival motor neuron protein 0.0058 0.0552 0.0956
Echinococcus granulosus TGF beta signal transducer SmadC 0.001 0.0056 0.0096
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0036 0.5
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0014 0.0095 0.0164
Brugia malayi CXXC zinc finger family protein 0.0035 0.0311 0.0538
Schistosoma mansoni serine/threonine protein kinase 0.0568 0.5778 1
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0008 0.0036 0.5
Schistosoma mansoni cpg binding protein 0.0035 0.0311 0.0538
Echinococcus granulosus mixed lineage leukemia protein mll 0.0009 0.0043 0.0075

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 11.2202 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 11.2202 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 12.5893 um PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 18.3489 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) = 19.9526 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 22.3872 um PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] ChEMBL. No reference
Potency (binding) = 22.3872 um PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] ChEMBL. No reference
Potency (functional) 25.1189 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] ChEMBL. No reference
Potency (functional) = 28.1838 um PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) = 28.1838 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] ChEMBL. No reference
Potency (functional) 28.1838 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 29.0929 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) 29.0929 uM PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 31.6228 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) = 39.8107 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 44.6684 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] ChEMBL. No reference
Potency (functional) 79.4328 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.